Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

AstraZeneca, Gilead Drug License Deals Could Pinch AbbVie Growth
TheStreet.com
Thu, 12/17/15 - 09:40 am
Tags:
AstraZeneca, Gilead Sciences, AbbVie, Acerta Pharma, Galapagos
Sovaldi is expensive, but this drug cost N.C. Medicaid even more
Bizjournals.com
Wed, 12/16/15 - 10:55 am
Tags:
Sovaldi, Gilead Sciences, drug pricing, North Carolina, Medicaid, Otsuka, Abilify
What can Gilead, Biogen and Celgene teach Big Pharma about R&D?
Fierce Biotech
Tue, 12/15/15 - 10:02 am
Tags:
Gilead Sciences, Biogen, Celgene, Big Pharma, R&D
This May Be The Fastest-Growing Biotech Stock Next Year (Hint: It's Not Gilead Sciences)
Motley Fool
Mon, 12/14/15 - 10:07 am
Tags:
Gilead Sciences, Regeneron
Mallinckrodt's Acthar Will Raise It Up, Not Bring It Down
Seeking Alpha
Sat, 12/12/15 - 01:54 pm
Tags:
Mallinckrodt, Acthar, Gilead Sciences, Valeant Pharmaceuticals
Will This Study Finally Catapult Gilead Sciences Into a Cancer Powerhouse?
Motley Fool
Thu, 12/10/15 - 10:39 am
Tags:
Gilead Sciences, Zydelig, CLL, chronic lymphocytic leukemia
Can new PhIII data help Gilead's Zydelig stage a comeback in CLL?
Fierce Pharma Marketing
Wed, 12/9/15 - 11:36 am
Tags:
Gilead Sciences, Zydelig, chronic lymphocytic leukemia, CLL
Sitting on $25B, Gilead goes shopping for high-dollar buyouts
Fierce Biotech
Tue, 12/8/15 - 10:43 pm
Tags:
Gilead Sciences, M&A
The 3 Most Important Drugs in Gilead Sciences' Pipeline
Motley Fool
Mon, 12/7/15 - 10:53 am
Tags:
Gilead Sciences, simtuzumab, Zydelig, Sovaldi + velpatasvir
The 5 pharma vets and 3 newcomers that made BCG's '50 most innovative' firms list
BioPharma Dive
Fri, 12/4/15 - 08:26 pm
Tags:
Gilead Sciences, Biogen, Roche, Bayer, JNJ, Amgen, innovation
Gilead Sciences: Hep-C ‘Tracking Fine’ But What About 2016?
Barron's
Fri, 12/4/15 - 08:22 pm
Tags:
Gilead Sciences, hepatitis C, Harvoni, Sovaldi
Gilead Sciences, Inc: Can the Senate Report Trigger Policy Changes?
Bidness, ETC
Thu, 12/3/15 - 09:35 am
Tags:
Gilead Sciences, drug pricing, Senate, hepatitis C
Gilead considered $115K price for Sovaldi, Senate investigation says
Fierce Pharma
Wed, 12/2/15 - 05:52 pm
Tags:
Gilead Sciences, Sovaldi, drug pricing, hepatitis C, Senate
Gilead put profit ahead of hepatitis C patients -U.S. Senate report
Yahoo/Reuters
Tue, 12/1/15 - 02:13 pm
Tags:
Gilead Sciences, hepatitis C, Senate
There's a 0.0000000000028% Chance This Drug Doesn't Work
Motley Fool
Tue, 12/1/15 - 10:12 am
Tags:
Gilead Sciences, Zydelig, chronic lymphocytic leukemia
Gilead Sciences Inc. Has Plenty of Room to Run in Hepatitis C
Motley Fool
Sat, 11/21/15 - 12:18 pm
Tags:
Gilead Sciences, hepatitis C, Sovaldi, Harvoni
Biotechs Go Low-Fat: Relevance To Amgen, Regeneron, The Medicines Company And Isis
Seeking Alpha
Thu, 11/19/15 - 04:39 pm
Tags:
Amgen, Regeneron, Medicines Company, Isis Pharmaceuticals, Gilead Sciences, Biogen
Gilead Sciences: AbbVie, Merck Fail to ‘Mount a Major Threat’
Barron's
Wed, 11/18/15 - 03:53 pm
Tags:
Gilead Sciences, AbbVie, Merck, hepatitis C
Is Merck & Co A Bigger-Than-Expected Threat To Gilead Sciences In HCV?
Bidness, ETC
Mon, 11/16/15 - 03:36 pm
Tags:
Merck, Gilead Sciences, hepatitis C, MK-3682, grazoprevir/elbasvir, MK-8408
5 Drugs That Are the Face of Prescription Drug Reform
Motley Fool
Sun, 11/15/15 - 11:31 am
Tags:
H.P. Acthar Gel, Mallinckrodt, Harvoni, Gilead Sciences, Orkambi, Vertex Pharmaceuticals, Isuprel, Nitropress, Valeant Pharmaceuticals

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.